VSTM2L and colorectal cancer: Taken together, these results indicated that overexpression of VSTM2L induced resistance to CRT in colorectal cancer cells through promoting cell proliferation and DNA damage repair and inhibiting cell apoptosis when cancer cells were treated with CRT.